The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Epigenetic changes in cancer
Abstract
A cancer develops when a cell acquires specific growth advantages through the stepwise accumulation of heritable changes in gene function. Basically, this process is directed by changes in two different classes of genes: Tumor suppressor genes that inhibit cell growth and survival and oncogenes that promote cell growth and survival. Since several alterations are usually required for a cancer to fully develop, the malignant phenotype is determined by the compound status of tumor suppressor genes and oncogenes. Cancer genes may be changed by several mechanisms, which potentially alter the protein encoding nucleotide template, change the copy number of genes, or lead to increased gene transcription. Epigenetic alterations, which, by definition, comprise mitotically and meiotically heritable changes in gene expression that are not caused by changes in the primary DNA sequence, are increasingly being recognized for their roles in carcinogenesis. These epigenetic alterations may involve covalent modifications of amino acid residues in the histones around which the DNA is wrapped, and changes in the methylation status of cytosine bases (C) in the context of CpG dinucleotides within the DNA itself. Methylation of clusters of CpGs called “CpG‐islands” in the promoters of genes has been associated with heritable gene silencing. The present review will focus on how disruption of the epigenome can contribute to cancer. In contrast to genetic alterations, gene silencing by epigenetic modifications is potentially reversible. Treatment by agents that inhibit cytosine methylation and histone deacetylation can initiate chromatin decondensation, demethylation and reestablishment of gene transcription. Accordingly, in the clinical setting, DNA methylation and histone modifications are very attractive targets for the development and implementation of new therapeutic approaches. Many clinical trials are ongoing, and epigenetic therapy has recently been approved by the United States Food and Drug Administration (US FDA) for use in the treatment of myelodysplastic syndrome (MDS) and primary cutaneous T‐cell lymphoma (CTCL).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Prósper, F., Heiniger, A., & Torres, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4944 · Cited by 128
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Self-citationThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Self-citationCpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Histone demethylation by a family of JmjC domain-containing proteins
Tsukada, Y.-I., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., & Zhang, Y. (2006) · Nature · doi:10.1038/nature04433 · Cited by 2,163
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
The DNA methyltransferases of mammals
Bestor, T. H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2395 · Cited by 2,041
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citationSilverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
The power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
Takai, D., & Jones, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052410099 · Cited by 1,514
Self-citationSaito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Self-citationMeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,275
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Issa, J.-P. J., Ottaviano, Y. L., Celano, P., Hamilton, S. R., Davidson, N. E., & Baylin, S. B. (1994) · Nature Genetics · doi:10.1038/ng0894-536 · Cited by 1,191
Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Two genetic hits (more or less) to cancer
Knudson, A. G. (2001) · Nature Reviews Cancer · doi:10.1038/35101031 · Cited by 1,127
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
Ehrlich, M., Gama-Sosa, M. A., Huang, L.-H., Midgett, R. M., Kuo, K. C., McCune, R. A., & Gehrke, C. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.8.2709 · Cited by 1,040
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham, J. M., Christensen, E. R., Tester, D. J., Kim, C. Y., Roche, P. C., Burgart, L. J., & Thibodeau, S. N. (1998) · PubMed · Cited by 863
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
The key to development: interpreting the histone code?
Margueron, R., Trojer, P., & Reinberg, D. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.01.005 · Cited by 749
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
Cloos, P. A. C., Christensen, J., Agger, K., Maiolica, A., Rappsilber, J., Antal, T., Hansen, K. H., & Helin, K. (2006) · Nature · doi:10.1038/nature04837 · Cited by 736
Accelerated age-related CpG island methylation in ulcerative colitis.
Issa, J. J., Ahuja, N., Toyota, M., Bronner, M. P., & Brentnall, T. A. (2001) · PubMed · Cited by 690
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
Phan, R. T., & Dalla-Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 679
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665
Self-citation5-Methylcytosine as an Endogenous Mutagen in the Human LDL Receptor and p53 Genes
Rideout, W. M., Coetzee, G. A., Olumi, A. F., & Jones, P. A. (1990) · Science · doi:10.1126/science.1697983 · Cited by 640
Self-citationSirtuins in aging and age-related disease
Longo, V. D., & Kennedy, B. K. (2006) · Cell · doi:10.1016/j.cell.2006.07.002 · Cited by 628
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer‐Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., & Minna, J. D. (2001) · PubMed · Cited by 608
Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., & Anderson, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503221102 · Cited by 593
Silverman, L. R., McKenzie, D. R., Peterson, B. L., Holland, J. F., Backstrom, J. T., Beach, C. L., & Larson, R. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4346 · Cited by 552
Brueckner, B., Garcia Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2957 · Cited by 545
Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P. A., & Lübbert, M. (2002) · Blood · doi:10.1182/blood.v100.8.2957 · Cited by 514
Self-citationBannister, A. J., & Kouzarides, T. (2005) · Nature · doi:10.1038/nature04048 · Cited by 502
Germline epimutation of MLH1 in individuals with multiple cancers
Suter, C. M., Martin, D. I. K., & Ward, R. L. (2004) · Nature Genetics · doi:10.1038/ng1342 · Cited by 475
Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0080 · Cited by 474
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.-G., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 447
Approval Summary: Azacitidine for Treatment of Myelodysplastic Syndrome Subtypes
Kaminskas, E., Farrell, A., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2135 · Cited by 423
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
Hammond, S. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.005 · Cited by 406
Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation
Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., & Baylin, S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020040 · Cited by 387
Feng, Z., Hu, W., Hu, Y., & Tang, M.-S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607031103 · Cited by 374
Methylation of the BRCA1 gene in sporadic breast cancer.
Dobrovic, A., & Simpfendorfer, D. (1997) · PubMed · Cited by 370
Hypermethylation of the DAP-Kinase CpG Island Is a Common Alteration in B-Cell Malignancies
Katzenellenbogen, R. A., Baylin, S. B., & Herman, J. G. (1999) · Blood · doi:10.1182/blood.v93.12.4347 · Cited by 345
Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer
Chan, T. L., Yuen, S. T., Kong, C. K., Chan, Y. W., Chan, A. S., Ng, W. F., Tsui, W. Y., Lo, M. W., Tam, W. Y., Li, V. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1866 · Cited by 324
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Fuino, L., Bali, P., Wittmann, S., Donapaty, S., Guo, F., Yamaguchi, H., Wang, H., Atadja, P. W., & Bhalla, K. N. (2003) · PubMed · Cited by 296
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
Mitsiades, N., Mitsiades, C. S., Richardson, P. G., McMullan, C., Poulaki, V., Fanourakis, G., Schlossman, R., Chauhan, D., Munshi, N. C., Hideshima, T., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3514 · Cited by 294
Esteller, M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.26 · Cited by 293
Vrana, J. A., Decker, R. H., Johnson, C. R., Wang, Z., Jarvis, W. D., Richon, V. M., Ehinger, M., Fisher, P. B., & Grant, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203176 · Cited by 284
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker, C., Millar, D., Paul, C. L., Warnecke, P. M., Harrison, E. M., Vincent, P., Frommer, M., & Clark, S. J. (1997) · PubMed · Cited by 272
Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong, J., Lo, K. W., To, K., Teo, P. M. L., Johnson, P. J., & Huang, D. P. (2002) · PubMed · Cited by 259
Causes and consequences of DNA hypomethylation in human cancer
Hoffmann, M. J., & Schulz, W. A. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-036 · Cited by 252
Cancer and ageing: a nexus at several levels
Balducci, L., & Ershler, W. B. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1675 · Cited by 250
Maiso, P., Carvajal-Vergara, X., Ocio, E. M., López-Pérez, R., Mateo, G., Gutiérrez, N., Atadja, P., Pandiella, A., & San Miguel, J. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4186 · Cited by 238
Jenuwein, T. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05343.x · Cited by 235
Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart, M. J., Tainton, K. M., Ruefli, A. A., Dear, A. E., Sedelies, K. A., O’Reilly, L. A., Waterhouse, N. J., Trapani, J. A., & Johnstone, R. W. (2003) · PubMed · Cited by 233
CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas
Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., & Ushijima, T. (2005) · Cancer Research · doi:10.1158/0008-5472.828.65.3 · Cited by 211
Jones, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn993 · Cited by 209
The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease
Ehrlich, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00201-8 · Cited by 203
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.
Wong, D. J., Barrett, M. T., Stöger, R. J., Emond, M. J., & Reid, B. J. (1997) · PubMed · Cited by 192
Yoon, J., Smith, L. E., Feng, Z., Tang, M., Lee, C.-S., & Pfeifer, G. P. (2001) · PubMed · Cited by 186
Aberrant methylations in cancer cells: Where do they come from?
Ushijima, T., & Okochi‐Takada, E. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00035.x · Cited by 185
Aging, DNA methylation and cancer
Issa, J.-P. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00019-0 · Cited by 185
Mori, Y., Cai, K., Cheng, Y., Wang, S., Paun, B., Hamilton, J. P., Jin, Z., Sato, F., Berki, A. T., Kan, T., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.006 · Cited by 185
An, C., Choi, I.-S., Yao, J. C., Worah, S., Xie, K., Mansfield, P. F., Ajani, J. A., Rashid, A., Hamilton, S. R., & Wu, T.-T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.656.11.2 · Cited by 183
Ushmorov, A., Leithäuser, F., Sakk, O., Weinhaüsel, A., Popov, S. W., Möller, P., & Wirth, T. (2006) · Blood · doi:10.1182/blood-2005-09-3765 · Cited by 179
HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma
Singh, T. R., Shankar, S., & Srivastava, R. K. (2005) · Oncogene · doi:10.1038/sj.onc.1208585 · Cited by 177
Aggerholm, A., Holm, M. S., Guldberg, P., Olesen, L. H., & Hokland, P. (2006) · European Journal of Haematology · doi:10.1111/j.1600-0609.2005.00559.x · Cited by 176
Diederichs, S., & Haber, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0537 · Cited by 176
Nakayama, M., Wada, M., Harada, T., Nagayama, J., Kusaba, H., Ohshima, K., Kozuru, M., Komatsu, H., Ueda, R., & Kuwano, M. (1998) · Blood · doi:10.1182/blood.v92.11.4296 · Cited by 172
Shinozaki, M., Hoon, D. S. B., Giuliano, A. E., Hansen, N. M., Wang, H.-J., Turner, R., & Taback, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1810 · Cited by 169
RUNX3 Inactivation by Point Mutations and Aberrant DNA Methylation in Bladder Tumors
Kim, W., Kim, E., Jeong, P., Quan, C., Kim, J., Li, Q.-L., Yang, J.-O., Ito, Y., & Bae, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1647 · Cited by 161
Yang, H., Liu, V. W. S., Wang, Y., Tsang, P. C. K., & Ngan, H. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-212 · Cited by 155
Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells
Nguyen, C., Liang, G., Nguyen, T. T., Tsao-Wei, D. D., Groshen, S. G., Lübbert, M., Zhou, J., Benedict, W. F., & Jones, P. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.19.1465 · Cited by 153
Self-citationAging and Cancer: Issues of Basic and Clinical Science
Ershler, W. B., & Longo, D. L. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1489 · Cited by 152
Ehrlich, M. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2424s · Cited by 138
Agrelo, R., Setién, F., Espada, J., Artiga, M. J., Rodríguez, M. E., Pérez‐Rosado, A., Sánchez‐Aguilera, A., Fraga, M. F., Piris, M. A., & Esteller, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.650 · Cited by 137
Aggerholm, A., Guldberg, P., Hokland, M., & Hokland, P. (1999) · PubMed · Cited by 134
Rosenbaum, E., Hoque, M. O., Cohen, Y., ZAHURAK, M. L., Eisenberger, M. A., Epstein, J. I., Partin, A. W., & Sidransky, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1183 · Cited by 134
Familial melanoma, pancreatic cancer and germline CDKN2A mutations
Goldstein, A. M. (2004) · Human Mutation · doi:10.1002/humu.9247 · Cited by 130
Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma
Pho, L. N., Grossman, D., & Leachman, S. A. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000208791.22442.09 · Cited by 125
Catalano, M. G., Fortunati, N., Pugliese, M., Poli, R., Bosco, O., Mastrocola, R., Aragno, M., & Boccuzzi, G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06970 · Cited by 125
Yeo, W., Wong, N., Wong, W., Lai, P. B. S., Zhong, S., & Johnson, P. J. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01084.x · Cited by 123
SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia
Chen, C.-Y., Tsay, W., Tang, J.-L., Shen, H., Lin, S.-W., Huang, S.-Y., Yao, M., Chen, Y.-C., Shen, M., Wang, C.-H., et al. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10222 · Cited by 121
Clément, G., Braunschweig, R., Pasquier, N., Bosman, F. T., & Benhattar, J. (2005) · The Journal of Pathology · doi:10.1002/path.1884 · Cited by 120
Imoto, I., Izumi, H., Yokoi, S., Hosoda, H., Shibata, T., Hosoda, F., Ohki, M., Hirohashi, S., & Inazawa, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4437 · Cited by 113
Wijermans, P., Lübbert, M., Verhoef, G. E. G., Klimek, V. M., & Bosly, A. (2005) · Annals of Hematology · doi:10.1007/s00277-005-0012-1 · Cited by 104
Fiskus, W. C., Pranpat, M., Balasis, M. E., Bali, P., Estrella, V. C., Kumaraswamy, S., Rao, R., Rocha, K., Herger, B. E., Lee, F. Y., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0980 · Cited by 102
Zebularine: A Unique Molecule for an Epigenetically Based Strategy in Cancer Chemotherapy
Márquez, V. E., Kelley, J. A., Agbaria, R., BEN‐KASUS, T., Cheng, J., Yoo, C. B., & Jones, P. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.037 · Cited by 100
Self-citationHaaf, T. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_2 · Cited by 100
Grønbæk, K., Worm, J., Ralfkiaer, E. M., Ahrenkiel, V., Hokland, P., & Guldberg, P. (2002) · Blood · doi:10.1182/blood-2002-02-0382 · Cited by 98
Self-citationWang, J., Lee, J. J., Wang, L., Liu, D. D., Lu, C., Fan, Y.-H., Hong, W. K., & Mao, L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0652 · Cited by 94
Shimamoto, T., Ohyashiki, J. H., & Ohyashiki, K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2004.11.014 · Cited by 90
Grønbæk, K., Brown, P. D. N., Møller, M. B., Nedergaard, T., Ralfkiaer, E. M., Mӧller, P., Zeuthen, J., & Guldberg, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401901 · Cited by 86
Self-citationHistone deacetylase inhibitors activate p21(WAF1) expression via ATM.
Ju, R., & Muller, M. T. (2003) · PubMed · Cited by 85
Sonnemann, J., Kumar, K., Heesch, S., Müller, C., Hartwig, C., Maass, M., Bader, P., & Beck, J. F. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.3.755 · Cited by 82
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitor
Sánchez‐González, B., Yang, H., Bueso-Ramos, C., Hoshino, K., Quintás‐Cardama, A., Richon, V. M., & Garcia‐Manero, G. (2006) · Blood · doi:10.1182/blood-2005-09-008086 · Cited by 82
Promoter Methylation and Response to Chemotherapy and Radiation in Esophageal Cancer
Hamilton, J. P., Sato, F., Greenwald, B. D., Suntharalingam, M., Krasna, M. J., Edelman, M. J., Doyle, A., Berki, A. T., Abraham, J. M., Mori, Y., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.007 · Cited by 81
Earel, J. K., VanOosten, R. L., & Griffith, T. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3017 · Cited by 80
Habuchi, T., Takahashi, T., Kakinuma, H., Wang, L., Tsuchiya, N., Satoh, S., Akao, T., Sato, K., Ogawa, O., Knowles, M. A., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204122 · Cited by 75
Zuo, C., Ai, L., Ratliff, P., Suen, J. Y., Hanna, E. Y., Brent, T. P., & Fan, C. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.967.13.6 · Cited by 73
Mutation Hotspots and DNA Methylation
Pfeifer, G. P., Tang, M.-S., & Denissenko, M. F. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_1 · Cited by 69
Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas
Luo, D., Zhang, B., Lv, L., Xiang, S., Liu, Y., Ji, J., & Deng, D. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700415 · Cited by 65
Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer
Lee, M. W., Han, W. S., Kim, O. K., Sung, S. H., Cho, M. S., Lee, S. N., & Koo, H. (2006) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.11.011 · Cited by 64
Côté, S., Rosenauer, A., Bianchini, A., Seiter, K. P., Vandewiele, J., Nervi, C., & Miller, W. H. (2002) · Blood · doi:10.1182/blood-2002-02-0614 · Cited by 63
Ab, G., Leyland-Jones, B., Hg, C., Davies, B., & Df, H. (1987) · PubMed · Cited by 56
Reddy, J., Shivapurkar, N., Takahashi, T., Parikh, G. Y., Stastny, V., Echebiri, C., Crumrine, K., Zöchbauer‐Müller, S., Drach, J. W., Zheng, Y., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208032 · Cited by 54
LHX6 is a sensitive methylation marker in head and neck carcinomas
Estecio, M. R., Youssef, E. M., Rahal, P., Fukuyama, E. E., Gois-filho, J. F., Maniglia, J. V., Goloni‐Bertollo, E. M., Issa, J. J., & Tajara, E. H. (2006) · Oncogene · doi:10.1038/sj.onc.1209509 · Cited by 52
Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma
Fukai, K., Yokosuka, O., Imazeki, F., Tada, M., Mikata, R., Miyazaki, M., Ochiai, T., & Saisho, H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01162.x · Cited by 50
Cited by
Epigenetic modifications of histones in cancer
Zhao, Z., & Shilatifard, A. (2019) · Genome Biology · doi:10.1186/s13059-019-1870-5 · Cited by 552
Mammalian DNA Methyltransferases: A Structural Perspective
Cheng, X., & Blumenthal, R. M. (2008) · Structure · doi:10.1016/j.str.2008.01.004 · Cited by 394
Delcuve, G. P., Rastegar, M., & Davie, J. R. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21678 · Cited by 384
Fast food fever: reviewing the impacts of the Western diet on immunity
Myles, I. A. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-61 · Cited by 380
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
Hoshida, Y., Toffanin, S., Lachenmayer, A., Villanueva, A., Minguez, B., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247131 · Cited by 310
Metadata
- Authors
- GRØNBÆK, K., HOTHER, C., & JONES, P. A.
- Venue
- APMIS
- Publisher
- Wiley
- Published
- 2007-10
- Volume
- 115
- Issue
- 10
- Pages
- 1039-1059
- ISSN
- 0903-4641 (ISSN-L)
- 1600-0463
- OpenAlex
- W2099521632
- Cited by
- 366
- References
- 124
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.